Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-U
NL-OMON59429Phase 3Recruiting
- Sponsor
- Heidelberg University
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in brain aneurysm (IA) (2 arms), sponsored by Heidelberg University. Primary endpoint: Aneurysm rupture or growth within 36±6 months. Started Apr 2018; status: recruiting.
02
Drugs
aspirin
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on NL-OMON59429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59429.